BioSpace News Archive

Baxter International, Inc. will host a conference call to discuss its first quarter 2018 financial results on Thursday, April 26, 2018, at 7:30 a.m. Central Daylight Time.

Agilent Technologies Inc. (NYSE: A) and BioTek Instruments, Inc. today announced a new, integrated solution that combines cellular metabolic analysis and imaging technologies.

Collaboration will provide clients competitive advantages, improve speed to market

Proceeds to advance lead oncology programs into the clinic and broaden early-stage pipeline

Both are accomplished executives with proven track records in building biopharmaceutical companies.

Company secures four oral presentations, including three that will highlight new data demonstrating activity of rezafungin against Candida auris and azole-resistant Aspergillus

Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company developing first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple cytokines to treat immuno-inflammatory diseases and T-cell malignancies, today announced that it has initiated a Phase 1/2 open-label clinical study of its lead product candidate BNZ-1

deltaFLU Outperformed Licensed Vaccine Against Drifted and Shifted Influenza Strains

Xyntek, a Global Leader in IT, Automation, & Compliance solutions have committed to participate in several upcoming industry technology shows and conferences in the upcoming months.

Pharos Diagnostics recently expanded testing services to provide routine testing capabilities in chemistry, hematology and immunoassay as well as Valley Fever (Coccidioidomycosis) testing